EMT has been previously associated with rapamycin resistance in breast cancer cell lines; rapamycin-resistance cells exhibit loss of E-cadherin, and expression of a constitutively active form of Snail decreases response to rapamycin of drug-sensitive cells37. Here, CDH1 is linked to breast cancer.